The clear winner is oral semaglutide, a GLP-1 drug now FDA-approved as a 25 mg pill for weight management since December 2025, with large human trials behind it
The bone and cartilage repair community learned this lesson early: incomplete protocols often produce no measurable benefit, and the same principle applies with even greater force to neurological applications where the biological timelines are longer
Sci Rep 6:31899 Chin Y-T, Wang L-M, Hsieh M-T, Shih Y-J, Nana AW, Changou CA, Yang Y-CS, Chiu H-C, Fu E et al (2017) Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells
For use within a few days or weeks, refrigeration at approximately 4C (39F) is generally sufficient
Methycobal) in chronic diabetic neuropathy
Retatrutides triple-receptor agonismmainly the inclusion of the glucagon receptorprovides a superior metabolic advantage in clearing liver fat and increasing thermogenesis compared to dual agonists